CSL Behring

CORIFACT

Manufacturer:

CSL Behring

Corifact HCPCS:

J7180

HCPCS Code Descriptor:

Injection, factor xiii (antihemophilic factor, human), 1 i.u.

Category:

J Code

Corifact NDCs:

63833-0518-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Corifact:

CORIFACT is a Hematology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J7180 is aligned to the drug CORIFACT.

ACCESS PRICING AND MORE BY REGISTERING

J7180 Added Date:

January 1, 2012

J7180 Effective Date:

January 1, 2023

J7180 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Corifact billing and coding information.
Corifact patient assistance information can be found through CSL Behring at the URL: https://www.cslbehring.com/patients/support-and-assistance
CORIFACT prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for CORIFACT. Please check back in a few weeks.